Navigation Links
Waxing And Waning Of Dengue Epidemics Attributed To Cross-Immunity

Researchers at the University of Georgia have suggested that cross-immunity created in response to infection by one serotype or viral strain protect against infection // by related serotypes thus leading to the waxing and waning of the Dengue epidemics. This finding would help understand the pattern of this deadly mosquito-borne illness better.

"We found that since about the mid 1980s, there's been a sequential replacement of the dominant serotype," said lead author Helen Wearing, a post-doctoral researcher at the UGA Institute of Ecology. "So, for example, one year serotype three is 60 percent of the cases and the next year serotype two is dominant and so on. Epidemics of individual serotypes recur every eight to 10 years, but, at the same time, if you look at all the data together, you see about an average three-year cycle with some seasonal component to it."

In addition to helping resolve a long-standing debate in public health, the study, published this week in the early online edition of the journal Proceedings of the National Academy of Sciences, gives researchers a framework that can be used to create models that predict dengue outbreaks in both space and time.

"It's a framework that highlights the key elements you need to take into account while developing a forecasting model," Wearing said. "Because if you were to build a forecasting model without understanding the trends in cross-immunity, you would not necessarily predict what we observe."

The researchers examined 30 years of data from the government of Thailand and from a Thai clinic that keeps what is widely regarded as the most comprehensive set of data on dengue. Southeast Asia has been a dengue hot spot since the 1950s, but the researchers note that their model applies to other regions where all four dengue strains circulate.

The researchers compared the data with results from mathematical models that explore – both independently and collective ly – the role factors such as temporary cross-immunity and variation in serotype virulence play in epidemics. They found that cross-immunity alone is enough to create the patterns that are observed in nature.

The study is a major departure from other theories about what drives dengue epidemics. The conventional wisdom is that an amplification of the severity of disease caused by repeat infections with different strains, a phenomenon known as antibody-dependent enhancement, drives the boom and bust cycles of dengue epidemics.

"Temporary cross-immunity has been ignored by the epidemiological community," said study co-author Pejman Rohani, associate professor of ecology and UGA Biomedical and Health Sciences Institute researcher.

"It's discussed in the scientific literature," Wearing added, "but no one ever considers it an important factor in generating the epidemiological cycles."

Cross-immunity, which lasts from two to nine months, results when overall antibody levels created by the body in response to infection by one serotype are high enough to protect against infection by related serotypes. After this period, however, antibody levels drop to levels that are no longer neutralizing but instead are exploited by the dengue virus to enhance replication and cause more severe illness.

"You can't deny the empirical fact that people who get severe dengue may well have had cases before," Rohani said. "But our work suggests it's not the mechanism that's underlying the big-picture pattern that we see."

Several factors are contributing to an increase in dengue epidemics. Global warming is allowing the species primarily responsible for spreading dengue (Aedes aegypti, also known as the yellow fever mosquito) to expand its range. Population growth in developing nations is pushing more people into substandard housing in mosquito-infested areas. And the ease of travel brings the virus to areas that were previously dengue-free when a mosquito bites an infected traveler and then spreads it to others. According to the Centers for Disease Control and Prevention, Aedes aegypti and the related Aedes albopictus (the Asian tiger mosquito) have the potential to spread dengue in sporadic outbreaks in the Southern and Southeastern United States.

Rohani said the same modeling techniques he and Wearing used to study dengue can help shed light on the transmission of other multi-strain diseases such as cholera, malaria and influenza. He calls a better understanding of such diseases, "one of the most important issues in public health and epidemiology in general."

"Until now, it's been very much a single-host, single-pathogen type of framework," Rohani said. "Now with avian influenza being very much on everyone's mind, we're beginning to realize that the genetic diversity of infectious agents is really important."

Source: Eurekalert
'"/>




Related medicine news :

1. Dengue Outbreak in Kolkata, Four Dead
2. Dengue in Delhi – 26 Cases reported and 3 dea
3. Dengue fever in Delhi after the Monsoon
4. Dengue Claims 15 Lives In West Bengal
5. Dengue Epidemic in West Bengal: Over 1000 New Cases and 15 dead
6. 45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
7. Vaccine For Dengue Fever On Trial In Asia-Pacific
8. Dengue Fever Claims Five Lives In Pakistan
9. Fear Of Dengue Epidemic Looms Large: Fever Kills Five in Pakistan
10. Delhi Launches Special Drive to Check Dengue Spread
11. MCD Takes Steps To Prevent, Control Dengue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work ... as “patient engagement.” The patient is doing more than filling out a survey; in ... “There is an increasing emphasis in health care and research on the importance of ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/12/2017)... LAKES, N.J. , Sept. 12, 2017  Consumer reviews on ... Embrace Hearing as the number one company for hearing aids, ... ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides ...
Breaking Medicine Technology: